Comparative efficacy of fenofibrate/pravastatin/ezetimibe and simvastatin/ezetimibe therapies in type 2 diabetic patients with combined hyperlipidaemia and cardiovascular disease

被引：0
|
作者：
Farnier, M. [1 ]
Steinmetz, A. [2 ]
Csaszar, A. [3 ]
Retterstol, K. [4 ]
Dluzniewski, M. [5 ]
机构：
[1] Point Med, Dijon, France
[2] St Nikolaus Stiftshosp GmbH, Andernach, Germany
[3] State Hlth Ctr, Budapest, Hungary
[4] Oslo Univ Hosp Rikshosp, Oslo, Norway
[5] Warsaw Hosp, Warsaw, Poland
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1296
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparative efficacy and safety of Fenofibrate/Pravastatin/Ezetimibe therapy and Simvastatin/Ezetimibe therapy in Type 2 Diabetic patients with combined hyperlipidemia and cardiovascular disease
    Farnier, M.
    Retterstol, K.
    Dluzniewski, M.
    Csazar, A.
    Steinmetz, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 601 - 601
  • [2] Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
    Farnier, Michel
    Retterstol, Kjetil
    Steinmetz, Armin
    Csaszar, Albert
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (03): : 205 - 215
  • [3] Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia
    Farnier, M
    Freeman, MW
    Macdonell, G
    Perevozskaya, I
    Davies, MJ
    Mitchel, YB
    Gumbiner, B
    EUROPEAN HEART JOURNAL, 2005, 26 (09) : 897 - 905
  • [4] Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia
    Farnier, Michel
    Roth, Eli
    Gil-Extremera, Blas
    Mendez, Gustavo F.
    Macdonell, Geraldine
    Hamlin, Constance
    Perevozskaya, Inna
    Davies, Michael J.
    Kush, Debra
    Mitchel, Yale B.
    AMERICAN HEART JOURNAL, 2007, 153 (02) : 335.e1 - 335.e8
  • [5] Addition of ezetimibe to the treatment of type 2 diabetic patients with hyperlipidaemia, uncontrolled with statin treatment
    Martínez-Martín, FJ
    Rosas, HR
    Martinez, IP
    Soriano, P
    Velasco, PLD
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 113 - 114
  • [6] Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients
    Furman, Amy
    Meier, Joy L.
    Malmstrom, Robert A.
    Lopez, Julio R.
    Schaefer, Saul
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (08): : 538 - 544
  • [7] EFFICACY AND SAFETY OF FENOFIBRATE 160 MG IN COMBINATION WITH PRAVASTATIN 40 MG IN TYPE 2 DIABETIC PATIENTS WITH COMBINED HYPERLIPIDEMIA AND WITHOUT CARDIOVASCULAR DISEASE
    Farnier, Michel
    Steinmetz, Armin
    Retterstol, Kjetil
    Dluzniewski, Miroslaw
    Csazar, Albert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [8] Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patients
    Gaudiani, LM
    Lewin, A
    Meneghini, L
    Perevozskaya, I
    Plotkin, D
    Mitchel, Y
    Shah, S
    DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 88 - 97
  • [9] Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease
    Abel, Tatjana
    Feher, Janos
    Dinya, Elek
    Eldin, Mohamed Gamal
    Kovacs, Attila
    MEDICAL SCIENCE MONITOR, 2009, 15 (12): : MS6 - MS11
  • [10] Efficacy and safety of co-administered ezetimibe/simvastatin (EZE/SIMVA) and fenofibrate (FENO) in patients with mixed hyperlipidemia
    Farnier, M.
    Roth, E.
    Gil-Extremera, B.
    Mendez, G. F.
    Perevozskaya, I.
    Hamlin, C.
    Macdonell, G.
    Davies, M.
    Kush, D.
    Mitchel, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 174 - 174
12345